If you’re building clinical AI and haven’t looked at Utah, you’re late. Companies pushing the limits of AI in healthcare are heading there because the state’s giving them flexibility other states won’t, and Endpoints News is tracking where that experiment goes next.
This is the “AI doctors” story: clinical AI operating in diagnostic or treatment roles, not back-office automation. Utah is the test track, and the companies arriving there are betting that Utah’s model becomes the national template before federal regulators close the window.
If Utah’s experiment produces real clinical outcomes, it becomes the model. Every other state will have to decide whether to adopt it or cede that regulatory territory to Utah’s early movers. The real question: which state sets the compliance terms for clinical AI first.
For founders building clinical AI tools, Utah’s regulatory posture is now a competitive variable in your go-to-market. A call to Utah’s health department might belong on your roadmap before your next FDA pre-submission meeting.
— Nathan Zakhary